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Abstract
Background: Fahr’s disease is a rare neurodegenerative disorder characterized by diffuse intracranial calcium
deposition and associated cell loss mainly in bilateral basal ganglia and dentate nuclei of the cerebellum. Subarachnoid
hemorrhage and epileptic syncope had been reported as acute presentation of Fahr’s disease. We here report a
36-year-old male Indonesian diagnosed as Fahr’s disease presenting with young-onset ischemic stroke.
Case presentation: A 36-year-old male Indonesian without prior systemic disease or neurologic disorder presented
with young-onset ischemic stroke involving the right posterior limb of internal capsule. Brain computed tomography
and magnetic resonance imaging demonstrated symmetric calcifications in bilateral basal ganglia, internal capsules,
cerebellar dentate nuclei, thalami, cerebral white matter, which were all consistent with Fahr’s disease. The laboratory
studies excluded the presence of other pathologic processes leading to secondary intracranial calcification. Other
young stroke surveys were unremarkable. After medical treatment and sustained physical rehabilitation for 3 months,
he recovered to carry out daily activities independently.
Conclusion: We present ischemic stroke in a young patient with sporadic Fahr’s disease. The differentiation between
Fahr’s disease and Fahr’s syndrome is specially highlighted when brain CT exhibits diffuse, symmetric calcifications in
bilateral basal ganglia, thalami, cerebellar dentate nuclei and cerebral white matter. The association between
nonarteriosclerotic vascular calcification and cerebrovascular disease is worth special attention and further investigation.
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Background
Fahr’s disease or idiopathic basal ganglia calcification
(IBGC) is a rare neurodegenerative disorder characterized
by diffuse, symmetric intracranial calcium deposition and
associated cell loss mainly in bilateral basal ganglia and
dentate nuclei of the cerebellum in the absence of other
causes leading to secondary calcification. The disorder
was first described by Karl Theodor Fahr in 1930 [1]. Pa-
tients usually present with chronic, progressive cognitive
deterioration, psychiatric problems and extrapyramidal
symptoms. The precise mechanism is not fully clear. It is
postulated that calcifications in Fahr’s disease may be at-
tributed to a metastatic deposition, secondary to local
disruption of blood–brain barrier (BBB), or disorder of
neuronal calcium phosphorus metabolism [2]. Fahr’s
disease can manifest as autosomal dominant, familial or
sporadic forms. Recent genetic research identified muta-
tions in SLC20A2, a gene located in the IBGC3 region that
encodes for type III sodium-dependent phosphate trans-
porter 2 (PiT2) as a major cause for dominantly inherited
Fahr’s disease [3]. In recent literatures, subarachnoid
hemorrhage and epileptic syncope had been reported as
acute presentation of Fahr’s disease [4, 5]. We here report
a 36-year-old male Indonesian diagnosed as Fahr’s disease
presenting with young-onset ischemic stroke. We review
the literature and discuss the association between Fahr’s
disease and cerebrovascular disease in this patient.
Case presentation
A 36-year-old male Indonesian who denied prior systemic
disease or neurologic disorder had been healthy and came
to Taiwan for 8 months, working as a labor of electronic
factory. No family history of cognitive impairment, move-
ment disorder or young-onset ischemic stroke was
obtained. He presented to our emergency department
* Correspondence: yashchun@gmail.com
1Department of Neurology, Taichung Tzu Chi Hospital, Buddhist Tzu Chi
Medical Foundation, No 88, Sec 1, Fongsing RdTanzi District, Taichung City
427, Taiwan
Full list of author information is available at the end of the article
© 2016 Yang et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Yang et al. BMC Neurology  (2016) 16:33 
DOI 10.1186/s12883-016-0557-8
because of acute onset of left limb weakness when he was
working on Nov 18th, 2014. At emergency room, the initial
vital signs were: blood pressure 156/95 mmHg, pulse 91
beats/min, respirations 16 breaths/min, body temperature
36 °C. The general physical examination was unremarkable.
No cardiac arrhythmia, heart murmur or carotid bruit was
observed. The neurologic examination revealed left hemi-
paresis with manual muscle power grade 4, mild dysarthria
and left central facial palsy. There was no cognitive impair-
ment, extrapyramidal signs or cerebellar ataxia. The score
of National Institutes of Health Stroke Scale (NIHSS) was
four points. Brain computed tomography (CT) showed ex-
tensive and symmetric calcifications involving the bilateral
basal ganglia, internal capsules, thalami, cerebral subcortical
white matter, cerebellar dentate nuclei and deep cerebellar
white matter (Fig. 1). The blood examinations at emer-
gency room were normal including coagulation profiles,
blood cell count and biochemistry profiles. He was admit-
ted to neurologic ward with the tentative diagnosis of
young-onset ischemic stroke.
At hospitalization, the causes of abnormal intracranial
calcification and young-onset stroke were investigated.
The level of serum calcium (2.20 mmol/L), phosphorus
(4.3 mg/dL), magnesium (2.1 mg/dL), alkaline phosphat-
ase (79 IU/L), calcitonin, thyroid hormone, parathyroid
hormone and enzyme-linked immunosorbant assay for
human immunodeficiency virus (HIV) were all within
normal limits. Brain magnetic resonance imaging (MRI)
revealed acute ischemic infarction involving the right
posterior limb of internal capsule and an old lacunar in-
farct involving the left genu of the internal capsule. In
addition, hypointense signal in T2 weighted images and
slightly hyperintense signal in T1 weighted images were
identified at bilateral basal ganglia, thalami, and cerebel-
lar dentate nuclei corresponding to the calcified lesions
(Fig. 2). Magnetic resonance angiography and venography
excluded intracranial large-vessel stenosis, aneurysm, vas-
cular malformation or dural sinus thrombosis. The
contrast-enhanced MRI excluded abnormal parenchymal
or leptomeningeal enhancement (Fig. 3). Cerebral perfusion
single-photon emission computed tomography (SPECT) of
the brain with 99mTc-hexamethylpropyleneamine oxime
(99mTc-HMPAO) demonstrated the presence of hypoper-
fusion in the bilateral basal ganglia and thalamic regions as
well as heterogeneous radiouptake in the bilateral cerebral
hemispheres and cerebellar hemispheres (Fig. 4). The
young stroke surveys including carotid artery duplex,
transthoracic cardiac echo, 24-h Holter, hematologic mea-
surements, D-dimer level (213.23 ng/mL), coagulation
profiles, autoimmune profiles, inflammation indices were
all unremarkable.
Aspirin with doses of 200 mg daily and adequate hydra-
tion was regularly administered. However, his left limb
weakness started to deteriorate on day 2 after admission
with NIHSS score rising to six points. There was no other
cortical function involvement. For stroke in evolution, low-
molecular-weight heparin with Dalteparin 2500 IU subcuta-
neously every 12 h had been given for 5 days and his left
hemiplegia gradually stabilized. After sustained physical re-
habilitation for 3 months, he recovered to carry out daily
activities independently. The score of NIHSS at discharge
was two points. The treatment resulted in favorable func-
tional outcome that was assessed by the modified Rankin
Scale score of 1 and the Barthel Index score of 100.
Conclusion
Fahr’s disease or idiopathic basal ganglia calcification is a
rare neurologic disorder with variable clinical presenta-
tions and distinctive neuroradiological features. According
to a registry of Fahr’s disease, symptomatic individuals
accounted for 67 % of the total population. Of the symp-
tomatic cases, the incidence among men was higher com-
pared with women and movement disorder was the most
common manifestation [6]. Brain CT remains a sensitive
tool to detect this excessive intracranial calcification be-
cause the calcium deposits are distinctly hyperdense.
However, the signal intensity is variable on MRI and de-
pends on the proton density of calcium and other mineral
ions, the concentration of binding proteins and mucopoly-
saccharides in different stages of the disease or different
metabolic states [7]. The common sites of calcifications in
Fahr’s disease are globus pallidus, putamen, caudate nu-
cleus, internal capsule, dentate nucleus, thalamus, and
cerebral white matter [8]. In our patient, brain MRI
Fig. 1 Axial noncontrast CT of the brain. Extensive and symmetric calcifications can be observed in a bilateral cerebellar dentate nuclei and
hemispheres, b bilateral basal ganglia, internal capsules, and thalami, and c bilateral cerebral subcortical white matter
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demonstrated different patterns in these calcified regions.
In T1 weighted images, hyperintense signals were only
recognized in bilateral basal ganglia, thalami and cerebel-
lar dentate nuclei.
Fahr’s disease needs to be distinguished from Fahr’s
syndrome in which basal ganglia calcification is attrib-
uted to secondary cause. The differential diagnosis of
pathologic basal ganglia calcification include idiopathic
hypoparathyroidism, secondary hypoparathyroidism,
hyperparathyroidism, post-thyroidectomy, birth anoxia,
cysticercosis, toxoplasmosis, calcified infarct, HIV infec-
tion…etc. [9]. In general, the distribution of intracranial
calcification tends to be extensive and symmetric in endo-
crine, toxic, metabolic or degenerative etiologies. The
pathologic calcified lesions secondary to infectious disease,
vascular insults or neoplasm are usually scattered and
asymmetric in the size and location [10, 11]. Detailed his-
tory taking and laboratory investigations are helpful in
determining the etiologies of pathologic intracranial calci-
fication. As for our patient, he had been well until this
event and does not have developmental anomaly, infection
signs or toxin exposure. He had no systemic disease,
metabolic disorder or hypoxia history. The thorough la-
boratory studies excluded the presence of other pathologic
processes. Brain CT, supplemented by MRI study exhib-
ited symmetric calcifications in the bilateral basal ganglia,
thalami, bilateral cerebral subcortical white matter,
cerebellar dentate nuclei and deep cerebellar white matter,
which were all consistent with Fahr’s disease. The patient
denied previous familial illness. Therefore, we considered
him a sporadic case of Fahr’s disease.
The association between young-onset ischemic stroke
and Fahr’s disease has yet to be determined. Transient
ischemic attack-like episodes had been linked to Fahr’s
disease in two case reports [12, 13]. However, there have
been no case reports demonstrating acute infarction in
Fahr’s disease with positive MRI findings and describing
the association with young-onset ischemic stroke. Be-
sides, this is the first case report of Fahr’s disease pre-
senting with ischemic stroke in Asian population. In
most cases with Fahr’s disease, although the age at onset
of neuropsychiatric symptoms is fourth to sixth decades
of life, highly variable clinical manifestations were also
reported in childhood-onset case, indicating phenotypic
heterogeneity and different functional impairment in
young-aged population [14]. In addition, the clinical pre-
sentations are also correlated with the calcified sites, the
amount of calcifications and consequently changes in
functional circuits [6, 15].
Due to uncertainty regarding the exact pathogenesis, a
plethora of descriptive terms have been used to describe
this disease. Different names of Fahr’s disease such as idio-
pathic nonarteriosclerotic calcification of cerebral vessels
and idiopathic familial cerebrovascular ferrocalcinosis
Fig. 2 The findings of brain MRI. a Acute ischemic infarction involving the right posterior limb of internal capsule presented as hyperintense area
in diffusion weighted images (arrowhead). b An old lacunar infarction involving the left genu of the internal capsule was seen in T2 weighted
images (arrowhead). c Nonenhanced T1 weighted images showed hyperintense signal in bilateral basal ganglia, thalami (arrowheads) and
cerebellar dentate nuclei (not shown)
Fig. 3 a Magnetic resonance angiography and b venography. No intracranial large-vessel stenosis, aneurysm, vascular malformation or dural sinus
thrombosis was observed. c The contrast-enhanced T1 weighted images showed no abnormal parenchymal or leptomeningeal enhancement
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reflect the etiology with the predilection of cerebral vascular
involvement [16]. Previous pathologic studies showed cal-
cium and other mineral deposits found in the walls of capil-
laries, arterioles, small veins and in the perivascular spaces
[17]. Electron microscopic study in post mortem cases also
revealed calcium deposits in the cytoplasm of adventitial
cells of blood vessels and sometimes in the cytoplasmic
processes of glial cells [18]. In addition, neuronal degener-
ation and gliosis surrounding these mineral accumulations
have been reported [19]. In many studies of coronary artery
disease, vascular calcification compromises arterial elas-
tance and vasomotor responses, leading to unstable angina
and myocardial infarction. Thus, vascular calcification is
regarded as an important risk factor of coronary heart dis-
ease [20]. In our case, a young healthy male had recurrent
ischemic infarction involving the bilateral internal capsules
respectively corresponding to the territory of smaller vessels
such as anterior choroidal arteries or perforating arteries.
These infarct lesions are deep and smaller than 1.5 cm in
diameter. We made the diagnosis of pure motor lacunar
syndrome and classified the etiologic subtype of ische-
mic stroke as small-artery occlusion based on the Trial
of Org 10172 in Acute Stroke Treatment (TOAST)
classification system [21]. Furthermore, the neuroimag-
ing features that support cardioembolic stroke or
malignancy-related embolic infarction, such as stroke in
multiple vascular territories, combined anterior and
posterior circulation or bilateral/multilevel posterior in-
farcts, were not observed in our patient’s pictures. Other
ancillary diagnostic studies excluded high risk sources of
cardioembolism and autoimmune disease-related ischemic
stroke. Normal D-dimer level and lacunar infarction ap-
pearance make the possibility of malignancy-related em-
bolic infarction less likely [22]. We therefore postulate
that the underlying pathogenic process of Fahr’s disease
results in extensive calcium and mineral deposits in af-
fected vessels and subsequently predisposes these subjects
to young-onset cerebrovascular disease. This presumptive
pathogenic mechanism is quite distinct from other
conventional etiologies that affect the small vessels includ-
ing arteriosclerosis, cerebral amyloid angiopathy and
immunologically-mediated small vessel diseases. Cerebral
perfusion SPECT of the brain with 99mTc-HMPAO is
useful in evaluating regional blood flow [23]. Reduced
blood flow to calcified regions is documented in our pa-
tient, which may lead to further focal ischemic change.
There is no specific treatment for Fahr’s disease to limit
the progression of brain calcification. Treatment is usually
symptomatic. The trial of treatment with central nervous
system-specific calcium channel blocker such as nimodi-
pine failed to confirm benefit [6]. In some preliminary
studies, disodium etidronate, a biphosphonate exhibited
Fig. 4 The features of cerebral perfusion SPECT. The presence of hypoperfusion in the bilateral basal ganglia and thalamic regions (arrowheads) as well
as heterogeneous radiouptake in the bilateral cerebral hemispheres and cerebellar hemispheres corresponded to those calcified areas in brain CT
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functional benefit and symptomatic improvement without
reduction in the amount of calcifications [24, 25]. We
treated the patient with antiplatelet agent initially and com-
bined anticoagulant agent during the stage of stroke in evo-
lution. The final neurologic outcome is good. Nevertheless,
the true prevalence of acute ischemic stroke in Fahr’s dis-
ease remains unknown due to lack of large-scale study.
In summary, we present ischemic stroke in a young
patient with sporadic Fahr’s disease. The differentiation
between Fahr’s disease and Fahr’s syndrome is specially
highlighted when brain CT shows diffuse, symmetric cal-
cifications in bilateral basal ganglia, thalami, cerebellar
dentate nuclei and cerebral white matter. The associ-
ation between nonarteriosclerotic vascular calcification
and cerebrovascular disease is worth special attention
and further investigation.
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